Nonetheless, our case series also has notable strengths
The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)
Rather than sit by and watch the wrinkles set in, you can actually feed your body the collagen its missing (a more natural way)
Alcohol consumption, in particular, places a massive burden on the liver, which can rapidly drain your glutathione reserves
Operator Tip If youre dispensing GLP-1s regularly, add two quick questions to your patient workflow: Have you noticed any change in your strength or energy? Are you doing anything to maintain muscle while on this medication? Even if the patient doesnt know what to say, it opens the door to educate, recommend follow-up, or refer to a specialist